戻る Agenda
Trans and Gender Diversity in Pharmacovigilance and Labelling
Session Chair(s)
James Bell
Director, Safety, Vigilance and Medical Affairs Quality Assurance
AbbVie, United Kingdom
Trans and Gender Diversity in Pharmacovigilance and Labelling